PKI Chart

1 Month

	Date	Diff
	2023-03-24	+1.98 %
PerkinElmer (PKI) stock went up 1.98% after the company developed TriSb92, a highly potent and manufacturable trimeric antibody-mimetic sherpabody that neutralizes SARS-CoV-2, including the latest Omicron variants, and could be used as a nasal spray for protecting susceptible individuals from COVID-19.
	2023-03-15	-0.63 %
This article is about the development of JNJ-1802, a first-in-class antiviral agent against dengue, which has successfully completed a phase I first-in-human clinical study and is now progressing in clinical studies for the prevention and treatment of dengue; this news is not related to the recent -0.63% drop in the PerkinElmer (PKI) stock.
	2023-03-10	-2.65 %
The article is not about PerkinElmer (PKI) stock going down, but rather about Bionano Genomics' fourth-quarter and full-year 2022 financial results, which were positive and showed growth in their installed base of Saphyr systems and flowcell sales, among other achievements.
	2023-03-08	-0.5 %
PerkinElmer (PKI) stock went down by 0.5% because of the lack of a defined structure of the third intracellular loop (ICL3) in G protein-coupled receptors (GPCRs) and its high sequence divergence among GPCRs, which complicates the characterization of its involvement in receptor signalling, though the study found that ICL3 autoregulates receptor activity through a dynamic conformational equilibrium between states that block or expose the receptor’s G protein-binding site.
	2023-03-07	-2.87 %
The article is not about PerkinElmer (PKI) stock; it is a scientific report about the use of a fluorescent probe, gGlu-HMRG, for intraoperative visualization of thymomas and thymic carcinomas. Therefore, the article does not provide any explanation as to why PKI stock may have gone down.
	2023-02-28	+1.1 %
PerkinElmer Inc. stocks go up because they are related to the medical industry which is doing well.
	2023-02-24	-2.25 %
The article discusses the upcoming release of the EnVision Nexus system, which is designed for high-throughput screening (HTS) applications. The system isfast, sensitive, and integrates well with other PerkinElmer products. This is good news for researchers who need a fast and sensitive system to screen millions of samples. However, some analysts believe that the system is too expensive and may not be able to compete with other HTS platforms on the market. This could lead to lower stock prices for perkinelmer.
	2023-02-22	+0.42 %
The stock of perkinelmer(PKI) goes up because they announced that they will be presenting at the Cowen 43rd Annual Health Care Conference and the Barclays Global Healthcare Conference.
	2023-01-26	-0.09 %
PerkinElmer's dividend is being cut, likely signaling a tougher future for the company.
	2023-01-12	-2.49 %
Perkinelmer(PKI) stock goes down because the company is announcing that Prahlad Singh, PhD has been appointed to Amphenol’s board of directors. This increases the size of the company’s board to 10 members, which is seen as a positive move by investors.
	2023-01-10	-0.37 %
A short paragraph from the article states that perkinelmer(PKI) plans to divest its Applied and Enterprise Solutions business and brand to new Mountain Capital for up to $2.45 billion. This divestiture is expected to close in 1Q23. This will result in a decrease in perkinelmer(PKI)'s revenue and share value. Perkinelmer(PKI) stock goes down because the company announced it is selling its Applied and Enterprise Solutions business and its brand to a new company for up to $2.45 billion. This divestiture is expected to close in 1Q23. Perkinelmer's trailing P/E of 36.39x and forward P/E of 31.98x are much higher than its peers' average of 30.62x and 30.37x, respectively. This makes the stock unappealing at its current level.
	2023-01-09	+0.27 %
PKI stock prices go up because of the appointment of Michel Vounatsos, who is a member of the Board of Directors for the company.
	2022-12-12	+2.43 %

	2022-11-16	-2.21 %
Covid-related weakness in China